Andrew Spaventa - 12 Nov 2024 Form 4 Insider Report for Singular Genomics Systems, Inc.

Role
Chief Executive Officer, Director
Signature
/s/ Dalen Meeter, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
12 Nov 2024
Net transactions value
-$15,669
Form type
4
Filing time
13 Nov 2024, 16:43:21 UTC
Previous filing
17 Sep 2024
Next filing
17 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OMIC Common Stock Options Exercise +1,907 +587% 2,232 12 Nov 2024 Direct F1
transaction OMIC Common Stock Sale $15,669 -695 -31% $22.54 1,537 12 Nov 2024 Direct F2
transaction OMIC Common Stock Gift $0 -1,212 -79% $0.000000 325 12 Nov 2024 Direct F3
transaction OMIC Common Stock Gift $0 +1,212 +0.86% $0.000000 141,487 12 Nov 2024 By The Andrew K. Spaventa Living Trust dated April 9, 2014 F3
holding OMIC Common Stock 85 12 Nov 2024 By Axon Holdings, LLC F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMIC Restricted Stock Units Options Exercise $0 -1,907 -7.1% $0.000000 24,780 12 Nov 2024 Common Stock 1,907 Direct F5, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares of Common Stock issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F2 The shares were sold pursuant to pre-established trading instructions solely to satisfy tax withholding obligations in connection with the partial vesting of previously granted RSUs.
F3 Immediately upon settlement of the vested RSUs, and following the withholding described above, the Reporting Person transferred the shares as a gift to The Andrew K. Spaventa Living Trust dated April 9, 2014.
F4 The shares are held directly by Axon Holdings, LLC. The managing member of Axon Holdings, LLC is Axon Managers, LLC. The Reporting Person is a managing member of Axon Managers, LLC and may be deemed to have shared voting and investment power over the shares held by Axon Holdings, LLC. The Reporting Person disclaims beneficial ownership of the shares except to the extent of his pecuniary interest therein.
F5 Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F6 The RSUs vest in 16 equal quarterly installments over four years measured from February 12, 2024.